Skip to main content
Missouri Medicine logoLink to Missouri Medicine
letter
. 2020 Nov-Dec;117(6):532–533.

Calling Marijuana “Medical” Makes It Safe? No Way!

Elizabeth Stuyt 1
PMCID: PMC7721421  PMID: 33311780

I want to commend Missouri Medicine and the editorial staff for helping to get the word out regarding the down sides of marijuana. I am an addiction psychiatrist and have been treating people with addiction and mental health issues for the last 30 years. When we first legalized medical marijuana in Colorado in 2000, I was not that worried about it. At the time I thought it would not have a significant impact on the people I see. However, the highest concentration of THC in the plant at that time was 5% and there were no concentrates. Over the last 20 years, without any governmental regulation, the industry has been allowed to dramatically increase the concentration of THC to where the average in the plant is now 18.8% and 69.4% in the concentrates, such as wax, shatter, dab, vape oil, with some up to 95% THC.

While there is evidence that marijuana can be beneficial for some medical conditions, the research supporting this has been done with THC concentrations less than 10% in the smoked plant.1 There is no legitimate research on the concentrates as a medical treatment and there is no research on 18 – 95% THC indicating it is efficacious for anything medical or safe for anyone. On the other hand, there are multiple studies from around the world showing serious problems with high potency THC including addiction, psychosis, depression, anxiety, sleep problems, suicide, and violence. Based on their experience, Dutch researchers have stated anything higher than 15% THC should be considered a hard drug, comparable to cocaine and ecstacy.2

Despite this lack of research on concentrates, the 2019 Colorado Regulated Marijuana Market Update3 demonstrates an increasing amount of concentrates in both the medical and recreational market with a higher percentage in the medical market (34% versus 32%). This means that a physician may recommend a medical marijuana card for a patient and may even make recommendations about using something that is low in THC and higher in CBD, but there is no “prescription” with product type, amount, method of delivery, etc. So, the patient goes to the dispensary and purchases concentrates because of the belief “more potent is more efficacious”. This is the travesty of our current “medical marijuana”; people are dabbing with a blow torch to get their “medicine.”

Sadly, the fact that we call this “medical” makes people believe it is safe. Kids are increasingly using concentrates. The 2019 Health Kids Colorado Survey reported 10.2% of high school students using marijuana are using dab4 compared to 3.7% of adults who use dab5 (nearly three times higher rate). More kids and adults are ending up in the emergency room with psychotic symptoms, panic attacks, suicidal ideation, or cannabis hyperemesis syndrome because of using high potency THC.6

According to the 2019 Market Update,3 Colorado has a much higher share of “heavy” marijuana consumers compared to the national average. Daily or near daily users constitute 6.1% of marijuana users in Colorado and they purchase 75.7% of the product. This is truly an industry profiting from addiction.

Before even considering adding recreational marijuana, Missouri should do better than we have in Colorado and first regulate your medical marijuana by following the science. Potency should be limited to less than 10 % THC. Concentrates, such as wax, shatter, dab have no place in medical dispensaries as there is no research demonstrating they are safe and effective for any medical condition. Medical marijuana should be on the Prescription Drug Monitoring Program. Prescribers should be fully educated regarding the down sides of marijuana and working within their scope of practice when making recommendations.

References

  • 1.Whiting PF, et al. Cannabinoids for medical use a systematic review and meta-analysis. JAMA. 2015;313:2456–2473. doi: 10.1001/jama.2015.6358. [DOI] [PubMed] [Google Scholar]
  • 2.Laar MV, et al. Limitations to the Dutch cannabis toleration policy, assumptions underlying the reclassification of cannabis above 15% THC. In J Drug Policy. 2016;34:58–64. doi: 10.1016/j.drugpo.2016.02.011. [DOI] [PubMed] [Google Scholar]
  • 3.2019 Regulated Marijuana Market Update. Colorado Department of Revenue, Marijuana Enforcement Division; [Google Scholar]
  • 4.Marijuana Health Monitoring Program, Colorado Department of Public Health & Environment. 2020 Data Sources: Healthy Kids Colorado Survey (HKCS) 2019 [Google Scholar]
  • 5.Marijuana Health Monitoring Program, Colorado Department of Public Health & Environment. Data Source: Behavioral Risk Factor Surveillance System (BRFSS) 2017–2018 2020 [Google Scholar]
  • 6.Shelton SK, et al. Why do patients come to the emergency department after using cannabis? Clinical Toxicology. 2020;58:453–459. doi: 10.1080/15563650.2019.1657582. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Missouri Medicine are provided here courtesy of Missouri State Medical Association

RESOURCES